Skip to main content
. 2022 Jun 17;3(1):sgac039. doi: 10.1093/schizbullopen/sgac039

Table 2.

Demographic and Clinical Characteristics of the Sample

CHR (n = 26) HV (n = 19) Test Statistic
Mean or Frequency (SD or %) (t, χ 2, or z) P
Age 17.60 (3.2) 18.03 (4.44) 0.37 .710
Female 16 (57.1) 7 (36.8) 2.68 .10
Family income
 <20k 5 (26.3) 5 (26.3) 0.11 .746
 20k–59.9k 4 (21.1) 5 (26.3)
 60k–99.9k 3 (15.8) 3 (15.8)
 ≥100k 7 (36.8) 6 (31.6)
Race 0.05 .831
 Black or African American 9 (34.6) 6 (31.6)
 White 9 (34.6) 11 (57.9)
 Asian 6 (23.1) 0 (0)
 ≥1 race 2 (7.7) 2 (10.5)
DSM diagnoses
 Mood disorder 19 (73.1)
 Anxiety disorder 24 (92.3)
 PTSD 8 (32)
 ADHD 10 (40)
 Substance use disorder 2 (8)
Medication
 Antipsychotic 6 (24)
 Antidepressant 8 (32)
 Stimulant 8 (32)
BASC-2 scales
 Depressive symptoms 53.32 (15.21) 43.78 (5.58) −2.87 .007
 Anxiety symptoms 53.48 (13.71) 44.67 (9.15) −2.53 .016
Violent traumas 0.52 (0.99) 0.47 (0.77) −0.17 .86
Total traumas 1.6 (1.73) 0.79 (0.79) −1.90 .063